AsteriaPharma GmbH is a bioscience company founded in 2011, based in the area of Heidelberg- Mannheim, aimed at developing and commercializing innovative therapy and research products to treat cancer and infectious disease.

AsteriaPharma performs pharmaceutical preclinical research projects in the fields of cancer therapy, immunotherapy and diagnostics.

AsteriaPharma develops technologies and products for drug discovery, including modified nucleotide analogs and modified cell lines.